Auxly Cannabis Group (XLY) Small Cap Growth Virtual Investor Conference 2025 summary
Event summary combining transcript, slides, and related documents.
Small Cap Growth Virtual Investor Conference 2025 summary
13 Dec, 2025Company overview and market position
Operates as a leading Canadian cannabis producer with about 6% market share and a top-selling brand, Back Forty.
Employs over 400 staff and distributes products to 97% of Canadian retail locations, focusing on dried flower, pre-rolls, and vapes.
Strategic partnership with Imperial Brands, which owns 20% of shares, supports technology and future international expansion.
Revenue has grown at a 60% CAGR since 2020, with strong profitability and cash flow.
Management team has deep industry experience and a history of navigating sector challenges.
Financial performance and capital allocation
Q3 2025 was a record quarter: CAD 39.9M net revenue (+20% YoY), 56% gross margin, and CAD 12.3M adjusted EBITDA (+48% YoY).
Net income reached CAD 20.5M, a 500%+ YoY improvement, driven by operational efficiency and product demand.
Ended Q3 with CAD 30M cash and a net debt-to-EBITDA ratio of 0.6x, reflecting a strengthened balance sheet.
Generated CAD 35M in cash flow from operations over 12 months, with an 83% EBITDA-to-cash conversion rate.
Plans for increased CapEx in 2026 to boost throughput and quality, while maintaining strong free cash flow.
Operations, innovation, and product strategy
Auxly Leamington facility produces 100,000 kg of dried flower annually, with room for expansion on owned land.
Leverages advanced automation for pre-rolls, resulting in top-selling SKUs and national leadership in non-infused pre-rolls.
Charlottetown facility drives vape innovation, with Back Forty leading the all-in-one vape segment and ongoing product launches.
Focuses on continuous product innovation, data-driven consumer insights, and operational excellence to sustain growth.
Recent launch of Southpoint brand targets premium segment with unique genetics and strong initial sales.
Latest events from Auxly Cannabis Group
- 2025 saw 24% revenue growth, 64% higher Adjusted EBITDA, and strong cash flow conversion.XLY
Q4 202526 Mar 2026 - Delivered 24% revenue growth in 2025 and leads Canadian cannabis with top brands and innovation.XLY
Investor presentation26 Mar 2026 - Q1 2025 saw 29% revenue growth, 48% gross margin, and a return to profitability, but liquidity risks persist.XLY
Q1 202511 Feb 2026 - Record Q2 2025 revenue, profit, and margins, with strong outlook and market leadership.XLY
Q2 202510 Feb 2026 - Net loss narrowed and debt fell, but going concern risk persists amid negative working capital.XLY
Q4 202410 Feb 2026 - Q3 2024 revenue, profit, and market share rose, but liquidity and debt risks persist.XLY
Q3 202410 Feb 2026 - Record Q2 revenue and margin gains, but going concern risks persist.XLY
Q2 202410 Feb 2026 - Q3 2025 delivered strong revenue and profit growth, with improved margins and reduced debt.XLY
Q3 202513 Nov 2025 - Record Q2 results and recapitalization position the company for profitable, efficient growth.XLY
Planet MicroCap Showcase: TORONTO 202523 Oct 2025